Your browser doesn't support javascript.
loading
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.
Sundar, Raghav; Huang, Kie-Kyon; Kumar, Vikrant; Ramnarayanan, Kalpana; Demircioglu, Deniz; Her, Zhisheng; Ong, Xuewen; Bin Adam Isa, Zul Fazreen; Xing, Manjie; Tan, Angie Lay-Keng; Tai, David Wai Meng; Choo, Su Pin; Zhai, Weiwei; Lim, Jia Qi; Das Thakur, Meghna; Molinero, Luciana; Cha, Edward; Fasso, Marcella; Niger, Monica; Pietrantonio, Filippo; Lee, Jeeyun; Jeyasekharan, Anand D; Qamra, Aditi; Patnala, Radhika; Fabritius, Arne; De Simone, Mark; Yeong, Joe; Ng, Cedric Chuan Young; Rha, Sun Young; Narita, Yukiya; Muro, Kei; Guo, Yu Amanda; Skanderup, Anders Jacobsen; So, Jimmy Bok Yan; Yong, Wei Peng; Chen, Qingfeng; Göke, Jonathan; Tan, Patrick.
Afiliação
  • Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Hospital, Singapore gmstanp@duke-nus.edu.sg raghav_sundar@nuhs.edu.sg.
  • Huang KK; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Kumar V; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Ramnarayanan K; The N.1 Institute for Health, National University of Singapore, Singapore.
  • Demircioglu D; Singapore Gastric Cancer Consortium, Singapore.
  • Her Z; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Ong X; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Bin Adam Isa ZF; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Xing M; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.
  • Tan AL; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.
  • Tai DWM; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Choo SP; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Zhai W; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.
  • Lim JQ; Diagnostic Development Hub (DxD), Agency for Science, Technology and Research, Singapore.
  • Das Thakur M; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Molinero L; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.
  • Cha E; Diagnostic Development Hub (DxD), Agency for Science, Technology and Research, Singapore.
  • Fasso M; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Niger M; Division of Medical Oncology, National Cancer Centre, Singapore.
  • Pietrantonio F; Division of Medical Oncology, National Cancer Centre, Singapore.
  • Lee J; Curie Oncology, Singapore.
  • Jeyasekharan AD; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.
  • Qamra A; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.
  • Patnala R; Department of Development Sciences, Genentech, San Francisco, California, USA.
  • Fabritius A; Department of Development Sciences, Genentech, San Francisco, California, USA.
  • De Simone M; Department of Development Sciences, Genentech, San Francisco, California, USA.
  • Yeong J; Department of Development Sciences, Genentech, San Francisco, California, USA.
  • Ng CCY; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rha SY; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Narita Y; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Muro K; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Hospital, Singapore.
  • Guo YA; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Skanderup AJ; Statistical Programming and Analytics, Roche Canada, Mississauga, Ontario, Canada.
  • So JBY; University Health Network, Toronto, Ontario, Canada.
  • Yong WP; Sci-illustrate, Munich, Germany.
  • Chen Q; Sci-illustrate, Munich, Germany.
  • Göke J; InSilico Genomics, Phoenix, Arizona, USA.
  • Tan P; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.
Gut ; 71(7): 1277-1288, 2022 07.
Article em En | MEDLINE | ID: mdl-34433583
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Gastrointestinais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Gastrointestinais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article